UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Signs, Symptoms, and Existing Patient-Reported outcome (Pro) Measures In Hospital-Acquired Bacterial Pneumonia (Habp): A Comprehensive Literature Review

Value in health, 2015-05, Vol.18 (3), p.A242-A242

2015

Volltextzugriff (PDF)

Development of a Patient-Reported outcome Instrument (Skinfect-Pro) To Standardize And Qualify Symptoms of Acute Bacterial Skin And Skin Structure Infection (Absssi) FNIH Biomarkers Consortium CABP ABSSSI Project Team ‘3

Value in health, 2015-05, Vol.18 (3), p.A242-A242

2015

Volltextzugriff (PDF)

Community-Acquired Bacterial Pneumonia (Cabp): Development of A New Patient-Reported Outcome (Pro) FNIH Biomarkers Consortium CABP ABSSSI Project Team ‘3

Value in health, 2015-05, Vol.18 (3), p.A242-A242

2015

Volltextzugriff (PDF)

Updated follow-up from KEYNOTE-057: Phase 2 study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG)

European urology open science (Online), 2020-07, Vol.19, p.e1173-e1174

2020

Volltextzugriff (PDF)

HEALTH‐RELATED QUALITY OF LIFE AMONG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL) IN A PHASE 3 STUDY OF PEMBROLIZUMAB VERSUS BRENTUXIMAB VEDOTIN

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

PRS61 MEASURING RESPIRATORY SYNCYTIAL VIRUS (RSV) SYMPTOM INTENSITY AND IMPACT IN ADULTS: CONTENT VALIDITY ASSESSMENT OF A PATIENT-REPORTED OUTCOME (PRO) MEASURE: THE RSV INFECTION INTENSITY AND IMPACT QUESTIONNAIRE (RSV-IIIQ)

Value in health, 2020-05, Vol.23, p.S360-S360

2020

Volltextzugriff (PDF)

PIN164 Measuring the Intensity of Dengue Illness: Modification of an Existing Patient-Reported Outcome Measure (PRO) in Low and Middle Income Countries

Value in health, 2020-12, Vol.23, p.S571-S571

2020

Volltextzugriff (PDF)

Health-related quality of life (HRQoL) and updated follow-up from KEYNOTE-057: Phase II study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guérin (BCG)

Annals of oncology, 2019-10, Vol.30, p.v364-v365

2019

Volltextzugriff (PDF)

916P - Health-related quality of life (HRQoL) and updated follow-up from KEYNOTE-057: Phase II study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guérin (BCG)

Annals of oncology, 2019-10, Vol.30, p.v364-v365

2019

Volltextzugriff (PDF)

PIN96 DEVELOPMENT OF PATIENT-REPORTED OUTCOME (PRO) AND OBSERVER-REPORTED OUTCOME (OBSRO) MEASURES FOR ASSESSMENT OF SYMPTOM INTENSITY IN DENGUE ILLNESS

Value in health, 2019-05, Vol.22, p.S210-S210

2019

Volltextzugriff (PDF)

916PHealth-related quality of life (HRQoL) and updated follow-up from KEYNOTE-057: Phase II study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guérin (BCG)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Hospital-Acquired Bacterial Pneumonia: Development of a New Patient-Reported Outcome Instrument

Value in health, 2016-05, Vol.19 (3), p.A221-A221

2016

Volltextzugriff (PDF)

PIN53 - Hospital-Acquired Bacterial Pneumonia: Development of a New Patient-Reported Outcome Instrument

Value in health, 2016-05, Vol.19 (3), p.A221-A221

2016

Volltextzugriff (PDF)

PIN83 - Development of a Patient-Reported outcome Instrument (Skinfect-Pro) To Standardize And Qualify Symptoms of Acute Bacterial Skin And Skin Structure Infection (Absssi) FNIH Biomarkers Consortium CABP ABSSSI Project Team ‘3

Value in health, 2015-05, Vol.18 (3), p.A242-A242

2015

Volltextzugriff (PDF)

PIN86 - Signs, Symptoms, and Existing Patient-Reported outcome (Pro) Measures In Hospital-Acquired Bacterial Pneumonia (Habp): A Comprehensive Literature Review

Value in health, 2015-05, Vol.18 (3), p.A242-A242

2015

Volltextzugriff (PDF)

PIN84 - Community-Acquired Bacterial Pneumonia (Cabp): Development of A New Patient-Reported Outcome (Pro) FNIH Biomarkers Consortium CABP ABSSSI Project Team ‘3

Value in health, 2015-05, Vol.18 (3), p.A242-A242

2015

Volltextzugriff (PDF)

CONTENT VALIDATION OF A NEW PATIENT-REPORTED OUTCOME (PRO) INSTRUMENT IN HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA (HABP)

Value in health, 2017-05, Vol.20 (5), p.A80

2017

Volltextzugriff (PDF)

PCR253 Establishing Content Validity of Three New Patient Reported Outcome (PRO) Measures for Use in HIV Long-Acting Oral Antiretroviral Therapy (LA-OART) Clinical Trials

Value in health, 2022-12, Vol.25 (12), p.S439-S439

2022

Volltextzugriff (PDF)

POSB377 Preliminary Psychometric Evaluation of the Respiratory Syncytial Virus Infection Intensity Impact Questionnaire (RSV-IIIQ) in Adults

Value in health, 2022-01, Vol.25 (1), p.S234-S234

2022

Volltextzugriff (PDF)

Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study

Onkourologii͡a, 2022-08, Vol.18 (2), p.39-57

2022

Volltextzugriff (PDF)

The Analyst's Narcissistic Vulnerability: Its Effect on the Treatment Situation

Contemporary psychoanalysis, 1980-01, Vol.16 (1), p.82-89

Saretsky, Ted

1980

Volltextzugriff (PDF)

The Resolution of Impasses in Borderline States

Contemporary psychoanalysis, 1977-01, Vol.13 (4), p.519-532

Saretsky, Ted

1977

Volltextzugriff (PDF)

Masochism and Ego Identity in Borderline States

Contemporary psychoanalysis, 1976-01, Vol.12 (4), p.433-445

Saretsky, Ted

1976

Volltextzugriff (PDF)

The therapist's way

Journal of contemporary psychotherapy, 1975-12, Vol.7 (1), p.56-59

Saretsky, Theodore

1975

Volltextzugriff (PDF)

Resistance in a group as a function of the therapist's countertransference expectations

Psychotherapy (Chicago, Ill.), 1972-01, Vol.9 (3), p.265-266

Saretsky, Theodore

1972

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(85)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Signs, Symptoms, and Existing Patient-Reported outcome (Pro) Measures In Hospital-Acquired Bacterial Pneumonia (Habp): A Comprehensive Literature Review

Development of a Patient-Reported outcome Instrument (Skinfect-Pro) To Standardize And Qualify Symptoms of Acute Bacterial Skin And Skin Structure Infection (Absssi) FNIH Biomarkers Consortium CABP ABSSSI Project Team ‘3

Community-Acquired Bacterial Pneumonia (Cabp): Development of A New Patient-Reported Outcome (Pro) FNIH Biomarkers Consortium CABP ABSSSI Project Team ‘3

Updated follow-up from KEYNOTE-057: Phase 2 study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG)

HEALTH‐RELATED QUALITY OF LIFE AMONG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL) IN A PHASE 3 STUDY OF PEMBROLIZUMAB VERSUS BRENTUXIMAB VEDOTIN

PRS61 MEASURING RESPIRATORY SYNCYTIAL VIRUS (RSV) SYMPTOM INTENSITY AND IMPACT IN ADULTS: CONTENT VALIDITY ASSESSMENT OF A PATIENT-REPORTED OUTCOME (PRO) MEASURE: THE RSV INFECTION INTENSITY AND IMPACT QUESTIONNAIRE (RSV-IIIQ)

PIN164 Measuring the Intensity of Dengue Illness: Modification of an Existing Patient-Reported Outcome Measure (PRO) in Low and Middle Income Countries

Health-related quality of life (HRQoL) and updated follow-up from KEYNOTE-057: Phase II study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guérin (BCG)

916P - Health-related quality of life (HRQoL) and updated follow-up from KEYNOTE-057: Phase II study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guérin (BCG)

PIN96 DEVELOPMENT OF PATIENT-REPORTED OUTCOME (PRO) AND OBSERVER-REPORTED OUTCOME (OBSRO) MEASURES FOR ASSESSMENT OF SYMPTOM INTENSITY IN DENGUE ILLNESS

916PHealth-related quality of life (HRQoL) and updated follow-up from KEYNOTE-057: Phase II study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guérin (BCG)

Hospital-Acquired Bacterial Pneumonia: Development of a New Patient-Reported Outcome Instrument

PIN53 - Hospital-Acquired Bacterial Pneumonia: Development of a New Patient-Reported Outcome Instrument

PIN83 - Development of a Patient-Reported outcome Instrument (Skinfect-Pro) To Standardize And Qualify Symptoms of Acute Bacterial Skin And Skin Structure Infection (Absssi) FNIH Biomarkers Consortium CABP ABSSSI Project Team ‘3

PIN86 - Signs, Symptoms, and Existing Patient-Reported outcome (Pro) Measures In Hospital-Acquired Bacterial Pneumonia (Habp): A Comprehensive Literature Review

PIN84 - Community-Acquired Bacterial Pneumonia (Cabp): Development of A New Patient-Reported Outcome (Pro) FNIH Biomarkers Consortium CABP ABSSSI Project Team ‘3

CONTENT VALIDATION OF A NEW PATIENT-REPORTED OUTCOME (PRO) INSTRUMENT IN HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA (HABP)

PCR253 Establishing Content Validity of Three New Patient Reported Outcome (PRO) Measures for Use in HIV Long-Acting Oral Antiretroviral Therapy (LA-OART) Clinical Trials

POSB377 Preliminary Psychometric Evaluation of the Respiratory Syncytial Virus Infection Intensity Impact Questionnaire (RSV-IIIQ) in Adults

Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study

The Analyst's Narcissistic Vulnerability: Its Effect on the Treatment Situation

The Resolution of Impasses in Borderline States

Masochism and Ego Identity in Borderline States

The therapist's way

Resistance in a group as a function of the therapist's countertransference expectations

Suchergebnisse filtern